ACM Research Reports Fourth Quarter and Fiscal Year 2024 Results
FREMONT, Calif., February 26, 2025 (Globe Newswire) – ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor
and advanced packaging applications, today reported financial results for its fourth quarter and fiscal year ended December 31, 2024.
“2024 was a year of strong execution for ACM. We expanded our product portfolio and broadened the addressable markets we serve,” said ACM’s President and Chief
Executive Officer, Dr. David Wang. “We grew revenue by 40% and total shipments by 63%. We gained additional market share by capitalizing on product cycles and deepening engagements with key customers, demonstrating the strength of our
multi-product portfolio. Our operating profit increased by 57.6%, and we generated $152 million in cash flow from operations.”
Dr. Wang continued, “In the fourth quarter, we achieved two major operational milestones. First, we achieved process qualification of our Thermal and Plasma-Enhanced
ALD furnace tools at two semiconductor customers in mainland China. Second, we commenced initial operations at our Lingang production facility, and we are on track to transition additional capacity to Lingang as we progress through the year.”
Dr. Wang concluded, “Looking ahead to 2025, we remain focused on expanding our business with incremental revenue contribution from Tahoe, SPM, and Furnace,
additional customer evaluations for both Track and PECVD, increasing localization in China, and contributions from our expanding global footprint. Regarding the addition of our subsidiaries to the U.S. Entity List, we believe the impact on the
ability of ACM Research (Shanghai) to produce tools will be manageable, and that we can continue to support our global customer base.”
| |
|
Three Months Ended December 31,
|
|
| |
|
GAAP
|
|
|
Non-GAAP(1)
|
|
| |
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
| |
|
(dollars in thousands, except EPS)
|
|
|
Revenue
|
|
$
|
223,471
|
|
|
$
|
170,321
|
|
|
$
|
223,471
|
|
|
$
|
170,321
|
|
|
Gross margin
|
|
|
49.6
|
%
|
|
|
46.4
|
%
|
|
|
49.8
|
%
|
|
|
46.8
|
%
|
|
Income from operations
|
|
$
|
43,989
|
|
|
$
|
23,374
|
|
|
$
|
52,773
|
|
|
$
|
36,046
|
|
|
Net income attributable to ACM Research, Inc.
|
|
$
|
31,080
|
|
|
$
|
17,700
|
|
|
$
|
37,740
|
|
|
$
|
28,681
|
|
|
Basic EPS
|
|
$
|
0.49
|
|
|
$
|
0.29
|
|
|
$
|
0.60
|
|
|
$
|
0.47
|
|
|
Diluted EPS
|
|
$
|
0.46
|
|
|
$
|
0.26
|
|
|
$
|
0.56
|
|
|
$
|
0.43
|
|
| |
|
Twelve Months Ended December 31,
|
|
| |
|
GAAP
|
|
|
Non-GAAP(1)
|
|
| |
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
| |
|
(dollars in thousands, except EPS)
|
|
|
Revenue
|
|
$
|
782,118
|
|
|
$
|
557,723
|
|
|
$
|
782,118
|
|
|
$
|
557,723
|
|
|
Gross margin
|
|
|
50.1
|
%
|
|
|
49.5
|
%
|
|
|
50.4
|
%
|
|
|
49.8
|
%
|
|
Income from operations
|
|
$
|
150,998
|
|
|
$
|
95,839
|
|
|
$
|
200,574
|
|
|
$
|
123,177
|
|
|
Net income attributable to ACM Research, Inc.
|
|
$
|
103,627
|
|
|
$
|
77,349
|
|
|
$
|
152,230
|
|
|
$
|
107,424
|
|
|
Basic EPS
|
|
$
|
1.67
|
|
|
$
|
1.29
|
|
|
$
|
2.45
|
|
|
$
|
1.79
|
|
|
Diluted EPS
|
|
$
|
1.53
|
|
|
$
|
1.16
|
|
|
$
|
2.26
|
|
|
$
|
1.63
|
|
| (1) |
Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to Non-GAAP
Financial Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share, also exclude unrealized gain (loss) on
short-term investments.
|
Outlook
ACM is maintaining its revenue guidance range of $850 million to $950 million for fiscal year 2025. This expectation is based on ACM management’s current assessment
of the continuing impact from international trade policy, together with various expected spending scenarios of key customers, supply chain constraints, and the timing of acceptances for first tools under evaluation in the field, among other
factors. We have updated our long-term business model to a gross margin target range of 42% to 48%, versus the prior range of 40% to 45%.
Operating Highlights and Recent Announcements
| • |
Shipments. Total shipments in 2024 were $973 million, up 63.1%. Total shipments in the fourth quarter of 2024 were $264 million, versus $140 million in the fourth quarter of 2023. Total shipments include deliveries
for revenue in the quarter and deliveries of first tool systems awaiting customer acceptance for potential revenue in future quarters.
|
| • |
Thermal and Plasma-Enhanced ALD furnace tools achieved process qualification. ACM announced the achievement of process qualification of its Ultra Fn A Plasma-Enhanced Atomic Layer Deposition (PEALD) and Thermal Atomic Layer Deposition (Thermal ALD) Furnace
tools at two mainland China semiconductor customers.
|
Full Year 2024 Financial Summary
Unless otherwise noted, the following figures refer to the full year of 2024 and comparisons are with the full year of 2023.
| • |
Revenue was $782.1 million, up 40.2%, reflecting higher sales of single wafer cleaning, Tahoe and semi-critical cleaning equipment and ECP (front-end and packaging), furnace and other technologies, along with steady
growth of advanced packaging (excluding ECP), services & spares.
|
| • |
Gross margin was 50.1% versus 49.5%.
Non-GAAP gross margin, which excludes stock-based compensation, was 50.4% versus 49.8%. Gross margin exceeded ACM’s updated long-term business model target range of 42% to 48%. ACM expects gross margin to vary from period to period due
to a variety of factors, such as product mix, currency impacts and sales volume.
|
| • |
Operating expenses were $240.6 million, an
increase of 33.4%. Operating expenses as a percentage of revenue decreased to 30.8% from 32.3%. Non-GAAP operating expenses, which exclude the effect of stock-based compensation, were $193.4 million, up 25.2%. Non-GAAP operating
expenses as a percentage of revenue were 24.7% compared to 27.7%.
|
| • |
Operating income was $151.0 million, up
57.6% compared to $95.8 million. Operating margin increased from 17.2% to 19.3%. Non-GAAP operating income, which excludes the effect of stock-based compensation, was $200.6 million, up 62.8% compared to 123.2 million. Non-GAAP
operating margin, which excludes stock-based compensation, was 25.6% compared to 22.1%.
|
| • |
Unrealized gain (loss) on short-term investments was $1.0 million, compared to an unrealized gain (loss) of $(2.7) million. Unrealized gain (loss) reflects the change in market value of the investments by ACM’s principal operating subsidiary, ACM Research (Shanghai), Inc. The
value is marked-to-market quarterly and is excluded in the non-GAAP financial metrics.
|
| • |
Income tax expense was $35.0 million,
compared to $19.4 million.
|
| • |
Net income attributable to ACM Research, Inc. was $103.6 million, compared to $77.3 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized gain (loss) on short-term investments, was $152.2
million, compared to $107.4 million.
|
| • |
Net income per diluted share attributable to ACM Research, Inc. was $1.53, compared to $1.16. Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized gain (loss) on short-term investments, was $2.26, compared to $1.63.
|
| • |
Cash and cash equivalents, plus restricted
cash and short-term and long-term time deposits were $441.9 million at December 31, 2024, compared to $369.1 million at September 30, 2024.
|
Fourth Quarter 2024 Financial Summary
Unless otherwise noted, the following figures refer to the fourth quarter of 2024 and comparisons are with the fourth quarter of 2023.
| • |
Revenue was $223.5 million, up 31.2%, reflecting higher sales of single wafer cleaning, Tahoe and semi-critical cleaning equipment and ECP (front-end and packaging), furnace and other technologies, along with steady sales growth of advanced packaging (excluding ECP), services & spares.
|
| • |
Gross margin was 49.6% versus 46.4%. Non-GAAP gross margin, which excludes stock-based compensation, was 49.8% versus 46.8%. Gross margin was at the upper end of ACM’s updated long-term business model target range of 42% to 48%. ACM expects gross margin to vary from period to period due to a variety of factors, such as product mix, currency impacts and sales volume.
|
| • |
Operating expenses were $66.8 million, an increase of 20.0%. Operating expenses as a percentage of revenue decreased to 29.9% from 32.7%. Non-GAAP operating expenses, which exclude the effect of stock-based compensation,
were $58.4 million, up 34.0%. Non-GAAP operating expenses as a percentage of revenue increased to 26.1% from 25.6%.
|
| • |
Operating income was $44.0 million, up 88.2% compared to $23.4
million. Operating margin was 19.7% compared to 13.7%. Non-GAAP operating income,
which excludes the effect of stock-based compensation, was $52.8 million, up 46.4% compared to $36.0 million. Non-GAAP operating margin, which excludes stock-based compensation, was 23.6% compared to 21.2%.
|
| • |
Unrealized gain on short-term investments was $2.1 million, compared to an unrealized gain of $1.7 million. Unrealized gain reflects the change in market value of the investments by ACM’s principal operating subsidiary, ACM Research (Shanghai), Inc. The value is marked-to-market quarterly and is excluded in the
non-GAAP financial metrics.
|
| • |
Income tax expense was $17.3 million, compared to $8.1 million.
|
| • |
Net income attributable to ACM Research, Inc. was $31.1 million, compared to $17.7 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized gain on short-term investments, was $37.7 million, compared to $28.7 million.
|
| • |
Net income per diluted share attributable to ACM Research, Inc. was $0.46, compared to $0.26. Non-GAAP net income per diluted share, which
excludes the effect of stock-based compensation and unrealized gain on short-term investments, was $0.56, compared to $0.43.
|
Conference Call Details
A conference call to discuss results will be held on Wednesday, February 26, 2025, at 8:00 a.m. Eastern Time (9:00 p.m. China Time). To join the conference call via
telephone, participants must use the following link to complete an online registration process. Upon registering, each participant will receive email instructions to access the conference call, including dial-in information and a PIN number
allowing access to the conference call. This pre-registration process is designed by the operator to reduce delays due to operator congestion when accessing the live call.
Online Registration: https://register.vevent.com/register/BI70ae79d80e0348a880269ad7a9dec2f9
Participants who have not pre-registered may join the webcast by accessing the link at ir.acmrcsh.com/events.
A live and archived webcast will be available on the Investors section of the ACM website at www.acmrcsh.com.
Use of Non-GAAP Financial Measures
ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc. and basic and diluted earnings per share as
supplemental measures to GAAP financial measures regarding ACM’s operational performance. These supplemental measures exclude the impact of stock-based compensation, which ACM does not believe is indicative of its core operating results. In
addition, non-GAAP net income attributable to ACM Research, Inc. and basic and diluted earnings per share exclude the effect of stock-based compensation and unrealized gain (loss) on short-term investments, which ACM also believes are not
indicative of its core operating results. A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure is provided below under “Reconciliation of GAAP to non-GAAP Financial Measures.”
ACM believes these non-GAAP financial measures are useful to investors in assessing its operating performance. ACM uses these financial measures internally to
evaluate its operating performance and for planning and forecasting of future periods. Financial analysts may focus on and publish both historical results and future projections based on the non-GAAP financial measures. ACM also believes it is in
the best interests of investors for ACM to provide this non-GAAP information.
While ACM believes these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of these
non-GAAP financial measures. These non-GAAP financial measures may not be reported by competitors, and they may not be directly comparable to similarly titled measures of other companies due to differences in calculation methodologies. The
non-GAAP financial measures are not an alternative to GAAP information and are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures. They should be used only as a supplement to GAAP information and
should be considered only in conjunction with ACM’s consolidated financial statements prepared in accordance with GAAP.
Forward-Looking Statements
Certain statements contained in this press release are not historical facts and may be forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Words such as “plans,” “expects,” “believes,” “anticipates,” “designed,” and similar words are intended to identify forward-looking statements. Forward-looking statements are based on ACM management’s current
expectations and beliefs, and involve a number of risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from those stated or implied by the forward-looking statements. A description of
certain of these risks, uncertainties and other matters can be found in filings ACM makes with the U.S. Securities and Exchange Commission, all of which are available at www.sec.gov. Because forward-looking statements involve risks and
uncertainties, actual results and events may differ materially from results and events currently expected by ACM. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. ACM
undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in its expectations with regard to these forward-looking statements or the
occurrence of unanticipated events.
About ACM Research, Inc.
ACM develops, manufactures and sells semiconductor process equipment spanning cleaning, electroplating, stress-free polishing, vertical furnace processes, track,
PECVD, and wafer- and panel-level packaging tools, enabling advanced and semi-critical semiconductor device manufacturing. ACM is committed to delivering customized, high-performance, cost-effective process solutions that semiconductor
manufacturers can use in numerous manufacturing steps to improve productivity and product yield. For more information, visit www.acmrcsh.com.
© ACM Research, Inc. ULTRA Fn and the ACM Research logo are trademarks of ACM Research, Inc. For convenience, these trademarks appear in this press release without ™
symbols, but that practice does not mean that ACM will not assert, to the fullest extent under applicable law, its rights to the trademarks.
For investor and media inquiries, please contact:
|
In the United States:
|
The Blueshirt Group
|
| |
Steven C. Pelayo, CFA
|
| |
(360)808-5154
|
| |
steven@blueshirtgroup.co
|
| |
|
|
In China:
|
The Blueshirt Group Asia
|
| |
Gary Dvorchak, CFA
|
| |
+86 (138) 1079-1480
|
| |
gary@blueshirtgroup.co
|
ACM RESEARCH, INC.
Condensed Consolidated Balance Sheets
| |
|
December 31, 2024
|
|
|
December 31, 2023
|
|
| |
|
(Unaudited)
|
|
|
|
|
| |
|
(In thousands)
|
|
|
Assets
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
407,445
|
|
|
$
|
182,090
|
|
|
Restricted cash
|
|
|
3,865
|
|
|
|
1,083
|
|
|
Short-term time deposits
|
|
|
17,277
|
|
|
|
80,524
|
|
|
Short-term investment
|
|
|
19,373
|
|
|
|
21,312
|
|
|
Accounts receivable, net
|
|
|
387,045
|
|
|
|
283,186
|
|
|
Other receivables
|
|
|
41,859
|
|
|
|
40,065
|
|
|
Inventories, net
|
|
|
597,984
|
|
|
|
545,395
|
|
|
Advances to related party
|
|
|
1,024
|
|
|
|
2,432
|
|
|
Prepaid expenses
|
|
|
7,507
|
|
|
|
20,023
|
|
|
Total current assets
|
|
|
1,483,379
|
|
|
|
1,176,110
|
|
|
Property, plant and equipment, net
|
|
|
269,272
|
|
|
|
201,848
|
|
|
Operating lease right-of-use assets, net
|
|
|
14,038
|
|
|
|
15,393
|
|
|
Intangible assets, net
|
|
|
3,461
|
|
|
|
2,538
|
|
|
Long-term time deposits
|
|
|
13,275
|
|
|
|
40,818
|
|
|
Deferred tax assets
|
|
|
14,781
|
|
|
|
20,271
|
|
|
Long-term investments
|
|
|
37,063
|
|
|
|
27,880
|
|
|
Other long-term assets
|
|
|
20,452
|
|
|
|
6,050
|
|
|
Total assets
|
|
$
|
1,855,721
|
|
|
$
|
1,490,908
|
|
|
Liabilities and Equity
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
Short-term borrowings
|
|
$
|
32,814
|
|
|
$
|
31,335
|
|
|
Current portion of long-term borrowings
|
|
|
44,472
|
|
|
|
6,783
|
|
|
Related party accounts payable
|
|
|
16,133
|
|
|
|
11,407
|
|
|
Accounts payable
|
|
|
139,294
|
|
|
|
141,814
|
|
|
Advances from customers
|
|
|
243,949
|
|
|
|
181,368
|
|
|
Deferred revenue
|
|
|
8,537
|
|
|
|
3,687
|
|
|
Income taxes payable
|
|
|
12,779
|
|
|
|
6,401
|
|
|
FIN-48 payable
|
|
|
19,466
|
|
|
|
12,149
|
|
|
Other payables and accrued expenses
|
|
|
121,657
|
|
|
|
102,951
|
|
|
Current portion of operating lease liability
|
|
|
2,132
|
|
|
|
2,764
|
|
|
Total current liabilities
|
|
|
641,233
|
|
|
|
500,659
|
|
|
Long-term borrowings
|
|
|
105,525
|
|
|
|
53,952
|
|
|
Long-term operating lease liability
|
|
|
3,840
|
|
|
|
4,262
|
|
|
Other long-term liabilities
|
|
|
9,217
|
|
|
|
5,873
|
|
|
Total liabilities
|
|
|
759,815
|
|
|
|
564,746
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
Equity:
|
|
|
|
|
|
|
|
|
|
Stockholders’ equity:
|
|
|
|
|
|
|
|
|
|
Class A Common stock
|
|
|
6
|
|
|
|
6
|
|
|
Class B Common stock
|
|
|
1
|
|
|
|
1
|
|
|
Additional paid-in capital
|
|
|
677,476
|
|
|
|
629,845
|
|
|
Retained earnings
|
|
|
260,000
|
|
|
|
156,827
|
|
|
Statutory surplus reserve
|
|
|
30,514
|
|
|
|
30,060
|
|
|
Accumulated other comprehensive loss
|
|
|
(63,372
|
)
|
|
|
(49,349
|
)
|
|
Total ACM Research, Inc. stockholders’ equity
|
|
|
904,625
|
|
|
|
767,390
|
|
|
Non-controlling interests
|
|
|
191,281
|
|
|
|
158,772
|
|
|
Total equity
|
|
|
1,095,906
|
|
|
|
926,162
|
|
|
Total liabilities and equity
|
|
$
|
1,855,721
|
|
|
$
|
1,490,908
|
|
ACM RESEARCH, INC.
Condensed Consolidated Statements of Operations and Comprehensive Income
| |
|
Three Months Ended December 31,
|
|
|
Year Ended December 31,
|
|
| |
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
| |
|
(Unaudited)
|
|
| |
|
( In thousands, except share and per share data)
|
|
|
Revenue
|
|
$
|
223,471
|
|
|
$
|
170,321
|
|
|
$
|
782,118
|
|
|
$
|
557,723
|
|
|
Cost of revenue
|
|
|
112,656
|
|
|
|
91,245
|
|
|
|
390,564
|
|
|
|
281,508
|
|
|
Gross profit
|
|
|
110,815
|
|
|
|
79,076
|
|
|
|
391,554
|
|
|
|
276,215
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
|
|
18,380
|
|
|
|
9,440
|
|
|
|
65,447
|
|
|
|
47,019
|
|
|
Research and development
|
|
|
27,750
|
|
|
|
32,465
|
|
|
|
105,473
|
|
|
|
92,709
|
|
|
General and administrative
|
|
|
20,696
|
|
|
|
13,797
|
|
|
|
69,636
|
|
|
|
40,648
|
|
|
Total operating expenses
|
|
|
66,826
|
|
|
|
55,702
|
|
|
|
240,556
|
|
|
|
180,376
|
|
|
Income from operations
|
|
|
43,989
|
|
|
|
23,374
|
|
|
|
150,998
|
|
|
|
95,839
|
|
|
Interest income
|
|
|
2,813
|
|
|
|
2,071
|
|
|
|
9,935
|
|
|
|
8,354
|
|
|
Interest expense
|
|
|
(1,228
|
)
|
|
|
(697
|
)
|
|
|
(4,151
|
)
|
|
|
(2,681
|
)
|
|
Realized gain from sale of short-term investments
|
|
|
1,344
|
|
|
|
478
|
|
|
|
1,788
|
|
|
|
9,047
|
|
|
Unrealized gain (loss) on short-term investments
|
|
|
2,124
|
|
|
|
1,691
|
|
|
|
973
|
|
|
|
(2,737
|
)
|
|
Other income (expense), net
|
|
|
7,061
|
|
|
|
(1,714
|
)
|
|
|
6,334
|
|
|
|
(1,558
|
)
|
|
Income from equity method investments
|
|
|
322
|
|
|
|
6,224
|
|
|
|
423
|
|
|
|
9,952
|
|
|
Income before income taxes
|
|
|
56,425
|
|
|
|
31,427
|
|
|
|
166,300
|
|
|
|
116,216
|
|
|
Income tax expense
|
|
|
(17,319
|
)
|
|
|
(8,129
|
)
|
|
|
(35,031
|
)
|
|
|
(19,364
|
)
|
|
Net income
|
|
|
39,106
|
|
|
|
23,298
|
|
|
|
131,269
|
|
|
|
96,852
|
|
|
Less: Net income attributable to non-controlling interests
|
|
|
8,026
|
|
|
|
5,598
|
|
|
|
27,642
|
|
|
|
19,503
|
|
|
Net income attributable to ACM Research, Inc.
|
|
$
|
31,080
|
|
|
$
|
17,700
|
|
|
$
|
103,627
|
|
|
$
|
77,349
|
|
|
Comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
39,106
|
|
|
|
23,298
|
|
|
|
131,269
|
|
|
|
96,852
|
|
|
Foreign currency translation adjustment, net of tax
|
|
|
(26,104
|
)
|
|
|
11,214
|
|
|
|
(15,728
|
)
|
|
|
(10,617
|
)
|
|
Unrealized gain on available-for-sale investments, net of tax
|
|
|
428
|
|
|
|
-
|
|
|
|
428
|
|
|
|
-
|
|
|
Comprehensive Income
|
|
|
13,430
|
|
|
|
34,512
|
|
|
|
115,969
|
|
|
|
86,235
|
|
|
Less: Comprehensive income attributable to non-controlling interests
|
|
$
|
4,909
|
|
|
$
|
5,807
|
|
|
$
|
26,365
|
|
|
$
|
17,689
|
|
|
Comprehensive income (loss) attributable to ACM Research Inc.
|
|
$
|
8,521
|
|
|
$
|
28,705
|
|
|
$
|
89,604
|
|
|
$
|
68,546
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.49
|
|
|
$
|
0.29
|
|
|
$
|
1.67
|
|
|
$
|
1.29
|
|
|
Diluted
|
|
$
|
0.46
|
|
|
$
|
0.26
|
|
|
$
|
1.53
|
|
|
$
|
1.16
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding used in computing per share amounts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
62,794,259
|
|
|
|
60,792,349
|
|
|
|
62,212,569
|
|
|
|
60,164,670
|
|
|
Diluted
|
|
|
66,518,704
|
|
|
|
65,911,901
|
|
|
|
66,237,424
|
|
|
|
64,870,543
|
|
ACM RESEARCH, INC.
Total Revenue by Product Category and by Region
| |
|
Three Months Ended December 31,
|
|
|
Year Ended December 31,
|
|
| |
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
| |
|
(Unaudited)
|
|
| |
|
($ in thousand)
|
|
|
Single wafer cleaning, Tahoe and semi-critical cleaning equipment
|
|
$
|
155,211
|
|
|
$
|
122,292
|
|
|
$
|
578,887
|
|
|
$
|
403,851
|
|
|
ECP (front-end and packaging), furnace and other technologies
|
|
|
51,695
|
|
|
|
32,133
|
|
|
|
151,057
|
|
|
|
103,356
|
|
|
Advanced packaging (excluding ECP), services & spares
|
|
|
16,565
|
|
|
|
15,896
|
|
|
|
52,174
|
|
|
|
50,516
|
|
|
Total Revenue By Product Category
|
|
$
|
223,471
|
|
|
$
|
170,321
|
|
|
$
|
782,118
|
|
|
$
|
557,723
|
|
| |
|
Three Months Ended December 31,
|
|
|
Year Ended December 31,
|
|
| |
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
|
Mainland China
|
|
$
|
223,110
|
|
|
$
|
165,441
|
|
|
$
|
775,752
|
|
|
$
|
540,969
|
|
|
Other Regions
|
|
|
361
|
|
|
|
4,880
|
|
|
|
6,366
|
|
|
|
16,754
|
|
|
Total Revenue By Region
|
|
$
|
223,471
|
|
|
$
|
170,321
|
|
|
$
|
782,118
|
|
|
$
|
557,723
|
|
ACM RESEARCH, INC.
Reconciliation of GAAP to Non-GAAP Financial Measures
As described under “Use of Non-GAAP Financial Measures” above, ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM
Research, Inc., and basic and diluted earnings per share as supplemental measures to GAAP financial measures, each of which excludes stock-based compensation (“SBC”) from the equivalent GAAP financial line items. In addition, non-GAAP net income
attributable to ACM Research, Inc., and basic and diluted earnings per share exclude unrealized gain (loss) on short-term investments. The following tables reconcile gross margin, operating expenses, operating income, net income attributable to
ACM Research, Inc., and basic and diluted earnings per share to the related non-GAAP financial measures:
| |
|
Three Months Ended December 31,
|
|
| |
|
2024
|
|
|
2023
|
|
| |
|
Actual
(GAAP)
|
|
|
SBC
|
|
|
Other non-
operating
adjustments
|
|
|
Adjusted
(Non-
GAAP)
|
|
|
Actual
(GAAP)
|
|
|
SBC
|
|
|
Other non-
operating
adjustments
|
|
|
Adjusted
(Non-
GAAP)
|
|
| |
|
(In thousands)
|
|
|
Revenue
|
|
$
|
223,471
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
223,471
|
|
|
$
|
170,321
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
170,321
|
|
|
Cost of revenue
|
|
|
(112,656
|
)
|
|
|
(365
|
)
|
|
|
-
|
|
|
|
(112,291
|
)
|
|
|
(91,245
|
)
|
|
|
(568
|
)
|
|
|
-
|
|
|
|
(90,677
|
)
|
|
Gross profit
|
|
|
110,815
|
|
|
|
(365
|
)
|
|
|
-
|
|
|
|
111,180
|
|
|
|
79,076
|
|
|
|
(568
|
)
|
|
|
-
|
|
|
|
79,644
|
|
|
Gross margin
|
|
|
49.6
|
%
|
|
|
0.2
|
%
|
|
|
-
|
|
|
|
49.8
|
%
|
|
|
46.4
|
%
|
|
|
0.3
|
%
|
|
|
-
|
|
|
|
46.8
|
%
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
|
|
(18,380
|
)
|
|
|
(1,907
|
)
|
|
|
-
|
|
|
|
(16,473
|
)
|
|
|
(9,440
|
)
|
|
|
(2,279
|
)
|
|
|
-
|
|
|
|
(7,161
|
)
|
|
Research and development
|
|
|
(27,750
|
)
|
|
|
(2,030
|
)
|
|
|
-
|
|
|
|
(25,720
|
)
|
|
|
(32,465
|
)
|
|
|
(3,628
|
)
|
|
|
-
|
|
|
|
(28,837
|
)
|
|
General and administrative
|
|
|
(20,696
|
)
|
|
|
(4,482
|
)
|
|
|
-
|
|
|
|
(16,214
|
)
|
|
|
(13,797
|
)
|
|
|
(6,197
|
)
|
|
|
-
|
|
|
|
(7,600
|
)
|
|
Total operating expenses
|
|
|
(66,826
|
)
|
|
|
(8,419
|
)
|
|
|
-
|
|
|
|
(58,407
|
)
|
|
|
(55,702
|
)
|
|
|
(12,104
|
)
|
|
|
-
|
|
|
|
(43,598
|
)
|
|
Income (loss) from operations
|
|
$
|
43,989
|
|
|
$
|
(8,784
|
)
|
|
$
|
-
|
|
|
$
|
52,773
|
|
|
$
|
23,374
|
|
|
$
|
(12,672
|
)
|
|
$
|
-
|
|
|
$
|
36,046
|
|
|
Unrealized gain on short-term investments
|
|
|
2,124
|
|
|
|
-
|
|
|
|
2,124
|
|
|
|
-
|
|
|
|
1,691
|
|
|
|
-
|
|
|
|
1,691
|
|
|
|
-
|
|
|
Net income (loss) attributable to ACM Research, Inc.
|
|
$
|
31,080
|
|
|
$
|
(8,784
|
)
|
|
$
|
2,124
|
|
|
$
|
37,740
|
|
|
$
|
17,700
|
|
|
$
|
(12,672
|
)
|
|
$
|
1,691
|
|
|
$
|
28,681
|
|
|
Basic EPS
|
|
$
|
0.49
|
|
|
|
|
|
|
|
|
|
|
$
|
0.60
|
|
|
$
|
0.29
|
|
|
|
|
|
|
|
|
|
|
$
|
0.47
|
|
|
Diluted EPS
|
|
$
|
0.46
|
|
|
|
|
|
|
|
|
|
|
$
|
0.56
|
|
|
$
|
0.26
|
|
|
|
|
|
|
|
|
|
|
$
|
0.43
|
|
| |
|
Year Ended December 31,
|
|
| |
|
2024
|
|
|
2023
|
|
| |
|
Actual
(GAAP)
|
|
|
SBC
|
|
|
Other non-
operating
adjustments
|
|
|
Adjusted
(Non-
GAAP)
|
|
|
Actual
(GAAP)
|
|
|
SBC
|
|
|
Other non-
operating
adjustments
|
|
|
Adjusted
(Non-
GAAP)
|
|
| |
|
(In thousands)
|
|
|
Revenue
|
|
$
|
782,118
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
782,118
|
|
|
$
|
557,723
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
557,723
|
|
|
Cost of revenue
|
|
|
(390,564
|
)
|
|
|
(2,385
|
)
|
|
|
-
|
|
|
|
(388,179
|
)
|
|
|
(281,508
|
)
|
|
|
(1,406
|
)
|
|
|
-
|
|
|
|
(280,102
|
)
|
|
Gross profit
|
|
|
391,554
|
|
|
|
(2,385
|
)
|
|
|
-
|
|
|
|
393,939
|
|
|
|
276,215
|
|
|
|
(1,406
|
)
|
|
|
-
|
|
|
|
277,621
|
|
|
Gross margin
|
|
|
50.1
|
%
|
|
|
0.3
|
%
|
|
|
-
|
|
|
|
50.4
|
%
|
|
|
49.5
|
%
|
|
|
0.3
|
%
|
|
|
-
|
|
|
|
49.8
|
%
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
|
|
(65,447
|
)
|
|
|
(10,552
|
)
|
|
|
-
|
|
|
|
(54,895
|
)
|
|
|
(47,019
|
)
|
|
|
(5,684
|
)
|
|
|
-
|
|
|
|
(41,335
|
)
|
|
Research and development
|
|
|
(105,473
|
)
|
|
|
(14,112
|
)
|
|
|
-
|
|
|
|
(91,361
|
)
|
|
|
(92,709
|
)
|
|
|
(8,459
|
)
|
|
|
-
|
|
|
|
(84,250
|
)
|
|
General and administrative
|
|
|
(69,636
|
)
|
|
|
(22,527
|
)
|
|
|
-
|
|
|
|
(47,109
|
)
|
|
|
(40,648
|
)
|
|
|
(11,789
|
)
|
|
|
-
|
|
|
|
(28,859
|
)
|
|
Total operating expenses
|
|
|
(240,556
|
)
|
|
|
(47,191
|
)
|
|
|
-
|
|
|
|
(193,365
|
)
|
|
|
(180,376
|
)
|
|
|
(25,932
|
)
|
|
|
-
|
|
|
|
(154,444
|
)
|
|
Income (loss) from operations
|
|
$
|
150,998
|
|
|
$
|
(49,576
|
)
|
|
$
|
-
|
|
|
$
|
200,574
|
|
|
$
|
95,839
|
|
|
$
|
(27,338
|
)
|
|
$
|
-
|
|
|
$
|
123,177
|
|
|
Unrealized gain (loss) on short-term investments
|
|
|
973
|
|
|
|
-
|
|
|
|
973
|
|
|
|
-
|
|
|
|
(2,737
|
)
|
|
|
-
|
|
|
|
(2,737
|
)
|
|
|
-
|
|
|
Net income (loss) attributable to ACM Research, Inc.
|
|
$
|
103,627
|
|
|
$
|
(49,576
|
)
|
|
$
|
973
|
|
|
$
|
152,230
|
|
|
$
|
77,349
|
|
|
$
|
(27,338
|
)
|
|
$
|
(2,737
|
)
|
|
$
|
107,424
|
|
|
Basic EPS
|
|
$
|
1.67
|
|
|
|
|
|
|
|
|
|
|
$
|
2.45
|
|
|
$
|
1.29
|
|
|
|
|
|
|
|
|
|
|
$
|
1.79
|
|
|
Diluted EPS
|
|
$
|
1.53
|
|
|
|
|
|
|
|
|
|
|
$
|
2.26
|
|
|
$
|
1.16
|
|
|
|
|
|
|
|
|
|
|
$
|
1.63
|
|
